Senores-new-logo-Oct-2023Senores-new-logo-Oct-2023Senores-new-logo-Oct-2023Senores-new-logo-Oct-2023
  • About Us
    • About Senores
    • Milestone
    • Leadership
    • Partnership
  • Manufacturing
    • Formulations
    • API
  • Products
    • Formulation – Regulated Market
    • Formulation – Emerging Market
    • API
    • Critical Care – Hospital Line
  • R&D
  • Investors
    • Offer Documents
    • Financials
    • Policies
    • Reports
    • Shareholding Pattern
    • Material Creditors
    • Committees
  • Contact

Financials
Financials of the Company
  • Senores Pharmaceuticals Ltd. Consolidated Financials FY 23-24
  • Senores Pharmaceuticals Ltd. Consolidated Financials FY 22-23
  • Senores Pharmaceuticals Ltd. Consolidated Financials FY 21-22
  • Senores Pharmaceuticals Ltd. Standalone Financials FY 23-24
  • Senores Pharmaceuticals Ltd. Standalone Financials FY 22-23
  • Senores Pharmaceuticals Ltd. Standalone Financials FY 21-22
Financials of Material Subsidiaries
  • Havix Group Inc. Financials FY 24
  • Ratnatris Pharmaceuticals Pvt. Ltd. Financials FY 24
  • Senores Pharmaceuticals Inc. Financials FY 24
  • Senores Pharmaceuticals Inc. Financials FY 22 & FY 23
Group Companies Data
  • Group Companies Data
Related Party Transactions
  • Related Party Transactions FY 22, FY 23 & FY 24

Useful Links

  • About Us
  • Manufacturing
  • Products
  • Partnership
  • R&D
  • Regulatory
  • ADR
  • Media
  • Career
  • Contact

Disclaimer

All the information present on Senores Pharmaceuticals website is not applicable to all the countries across the world. The purpose of this website is to provide information about Senores Pharmaceuticals' products and services. Any information present on the website shouldn't be misused or construed to spread or promote any of the products in the countries where are disapproved or prohibited.

© 2023 Senores Pharmaceuticals | All Rights Reserved.